We are thrilled to announce that the first article stemming from our project has been officially published in the prestigious journal, MDPI Diagnostics. This publication marks a significant milestone in our research journey, and we are excited to share the outcomes of our work with the scientific community and the public at large.
The article, titled Clinical Evaluation of a New Spectral-Domain Optical Coherence Tomography-Based Biometer delves into the validation of biometric measurements obtained by the VEMoS-AXL new optical biometer based on spectral domain optical coherence tomography (SD-OCT) by its comparison with a swept-source optical coherence tomography biometer (SS-OCT).
This achievement wouldn’t have been possible without the hard work and dedication of our research team, along with the ongoing support from our collaborators among which are: Jorge L. Alió (MD, PhD, FEBOphth, Vissum Grupo Miranza, Spain), Marina José-Martínez (Biomed. Eng., Vissum Grupo Miranza, Spain), Antonio Martínez-Abad (PhD Clinical optometrist, Vissum Grupo Miranza, Spain), Alejandra E. Rodríguez (Coord. R&D, Vissum Grupo Miranza, Spain), Francesco Versaci (R&D Eng., CSO, Italy), Jesper Hjortdal (Clinical Professor, AUH, Denmark), Joaquim Neto Murta (MD, PhD, CHUC, Portugal), Ana B. Plaza-Puche (PhD Clinical optometrist, Vissum Grupo Miranza, Spain), Mario Cantó-Cerdán (PhD Clinical optometrist, Vissum Grupo Miranza, Spain), David P. Piñero (PhD Clinical optometrist, Universidad Alicante, Spain).
We invite all those interested in our research to read the full article in MDPI Diagnostics through the following link: https://doi.org/10.3390/diagnostics14050560. We hope that this work contributes to advancing knowledge in Optical Coherence Tomography (OCT) Imaging in Ophthalmology and fosters future research in related areas.
Thank you to everyone who has contributed to this achievement, and we look forward to sharing more exciting news about our project in the future!